TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Open Access
- 6 April 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (20) , 33666-33675
Abstract
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosisKeywords
This publication has 50 references indexed in Scilit:
- Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancerBritish Journal of Cancer, 2016
- Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line DaudiTumor Biology, 2015
- Hiwi facilitates chemoresistance as a cancer stem cell marker in cervical cancerOncology Reports, 2014
- Signaling in Innate Immunity and InflammationCold Spring Harbor Perspectives in Biology, 2012
- Immunohistochemical study of NF-κB p65, c-IAP2 and caspase-3 expression in cervical cancerOncology Letters, 2012
- RETRACTED: Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathwayBiochemical Pharmacology, 2011
- Crosstalk in NF-κB signaling pathwaysNature Immunology, 2011
- A Cytoplasmic ATM-TRAF6-cIAP1 Module Links Nuclear DNA Damage Signaling to Ubiquitin-Mediated NF-κB ActivationMolecular Cell, 2010
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanismCell, 1986